Tifcemalimab (Synonyms: JS004) |
Catalog No.GC70029 |
Tifcemalimab (JS004) is a humanized monoclonal antibody against BTLA (B and T lymphocyte attenuator). Tifcemalimab blocks the inhibitory signaling pathway mediated by BTLA by binding to it and blocking the interaction between HVEM-BTLA. Tifcemalimab can be used for cancer research.
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
Review for Tifcemalimab
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)Review for Tifcemalimab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *